ALFA Filings
Every announcement, straight from the exchange
Every Beta Drugs other announcement announcement on NSE and BSE, newest first, each with its own page.
Time
3 announcements
Beta Drugs Limited submitted its quarterly Statement of Deviation or Variation for the preferential issue proceeds, confirming no deviation from the stated objects.
Beta Drugs Limited submitted its quarterly Monitoring Agency Report for June 2026. The report tracks the utilization of Rs. 117.01 Crore raised via preferential issues.
Beta Drugs Limited submitted its quarterly compliance certificate for the period ended March 31, 2026. The certificate confirms that security certificates received for dematerialisation were processed and the name of the depositories substituted in the register of members within prescribed timelines. This is a routine regulatory filing with no material financial impact.